A retrospective single center study to evaluate outcomes in patients who were transitioned from immediate-release tacrolimus to extended release tacrolimus in heart transplantation
Latest Information Update: 02 Aug 2022
Price :
$35 *
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Heart transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress
- 22 May 2020 New trial record
- 25 Apr 2020 Results presented at the 40th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation